Article info

Review
Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects
Free

Authors

  1. Correspondence to Dr Jason Charles Ray, Neurology, Alfred Health, Melbourne, VIC 3004, Australia; j.ray{at}alfred.org.au
View Full Text

Citation

Ray JC, Kapoor M, Stark RJ, et al
Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects

Publication history

  • Received July 25, 2020
  • Revised November 17, 2020
  • Accepted December 16, 2020
  • First published January 25, 2021.
Online issue publication 
November 16, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.